OC-0501 Chemo-RT plus induction or consolidation chemotherapy for rectal cancer: a randomised phase 2 trial
Emmanouil Fokas(Düsseldorf University Hospital), Claus Rödel(Goethe University Frankfurt), Jürgen Weitz(University Hospital Carl Gustav Carus), Gunnar Folprecht, Ludger Staib(Klinikum Esslingen), Rainer Fietkau(Friedrich-Alexander-Universität Erlangen-Nürnberg), Lutz Jacobasch(Orthopädische Praxis), Thomas Brunner(Medical University of Graz), Bülent Polat(University of Würzburg), Wolf O. Bechstein(Unknown), Anca‐Ligia Grosu(University of Freiburg), Matthias Schwarzbach, G. Klautke, Tim Friede(Universitätsmedizin Göttingen), Gerhard G. Grabenbauer(Klinikum Coburg), R.D. Hofheinz, Thomas Kuhnt(Leipzig University), A. Schleska-Lange, M. Ghadimi, Michael Allgäuer(Heidelberg University), Robert Grützmann(University Hospital Carl Gustav Carus), V. Paolucci, W. Schmiegel
Cited by 0
Related Papers
Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)
|Surgery|2011|2.3k
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
|The Lancet|2008|1.9k